Childrens’ Urinary MicroRNAs Predict Future Development of Heart or Kidney Diseases
|
By LabMedica International staff writers Posted on 08 Mar 2021 |

Image: Exosomes are 30-150 nanometer extracellular vesicles containing various cargoes such as RNA and proteins (Photo courtesy of Wikimedia Commons)
A panel of microRNAs isolated from the urine of young children was shown to be able to predict the likelihood that a child would develop heart or kidney disease later in life.
MicroRNAs (miRNAs) are short, non-coding RNAs of approximately 20 nucleotides that act as post-transcriptional regulators by modifying target gene expression. Urinary miRNAs are promising biomarkers of subclinical kidney damage or dysfunction because they reflect kidney signaling and histological changes at the molecular level, enabling early detection of chronic kidney disease or progression of acute kidney injury. Urinary miRNAs are also readily obtained and are stable in stored samples.
Exosomes contain the major fraction of miRNA in urine and consequently are an ideal target to probe for molecular biomarkers of kidney diseases. Exosomes are lipid-enclosed extracellular vesicles measuring 30–150 nanometers in diameter that are released by most cells in the body and play an important role in intercellular communication by carrying bioactive molecules (soluble proteins and nucleic acids such as miRNAs) to a target cell. Exosomes in urine are primarily released from renal epithelial cells derived from renal tubular structures and hold promise as one component of a noninvasive liquid biopsy for detecting molecular changes in distinct nephron regions even in the absence of disease. Thus, the study of miRNA expression in exosomes (exo-miR) presents an opportunity in biomarker discovery for blood pressure (BP) regulation and altered renal signaling by identifying new diagnostic biomarkers and therapeutic targets.
In this light, investigators at the Mount Sinai School of Medicine (New York, NY, USA) sought to understand the relationship between urinary exo-miR expression and children's BP and estimated glomerular filtration rate (eGFR) as well as urinary sodium and potassium levels as correlates of heart and kidney health.
For this study, the investigators extracted exo-miRs from urine samples obtained from 88 healthy Mexican children aged four to six years. The study was conducted in Mexico, since children there are considered to be at much higher risk than American children for many heart and kidney problems. Differential centrifugation of spot urines enabled isolation and detection of 193 exo-miRs. Linear regression was then used to analyze the relationship between the extracted exo-miRs and children's BP, eGFR, and urine electrolyte levels.
Results revealed that three exo-miRs had increased expression with urinary sodium, 17 with urinary sodium-to-potassium ratio, and one with decreased estimated glomerular filtration rate.
"Our findings are encouraging for future studies of noninvasive indicators of kidney and heart health, especially for individuals at an increased risk of kidney dysfunction," said senior author Dr. Alison Sanders, assistant professor of environmental medicine, public health, and pediatrics at Mount Sinai School of Medicine. "Further research may discover different combinations of miRNAs that could inform early diagnosis of a wide range of kidney and cardiac diseases. So many children around the world are at risk of developing cardiorenal problems which can impact their health throughout their lives. Assessment of microRNA expression on a targeted scale could present valuable opportunities to detect and intervene with kidney disease before it can progress. That is why we are so encouraged by our team's work in this vital field."
The urinary microRNA study was published in the February 26, 2021, online edition of the journal Epigenomics.
Related Links:
Mount Sinai School of Medicine
MicroRNAs (miRNAs) are short, non-coding RNAs of approximately 20 nucleotides that act as post-transcriptional regulators by modifying target gene expression. Urinary miRNAs are promising biomarkers of subclinical kidney damage or dysfunction because they reflect kidney signaling and histological changes at the molecular level, enabling early detection of chronic kidney disease or progression of acute kidney injury. Urinary miRNAs are also readily obtained and are stable in stored samples.
Exosomes contain the major fraction of miRNA in urine and consequently are an ideal target to probe for molecular biomarkers of kidney diseases. Exosomes are lipid-enclosed extracellular vesicles measuring 30–150 nanometers in diameter that are released by most cells in the body and play an important role in intercellular communication by carrying bioactive molecules (soluble proteins and nucleic acids such as miRNAs) to a target cell. Exosomes in urine are primarily released from renal epithelial cells derived from renal tubular structures and hold promise as one component of a noninvasive liquid biopsy for detecting molecular changes in distinct nephron regions even in the absence of disease. Thus, the study of miRNA expression in exosomes (exo-miR) presents an opportunity in biomarker discovery for blood pressure (BP) regulation and altered renal signaling by identifying new diagnostic biomarkers and therapeutic targets.
In this light, investigators at the Mount Sinai School of Medicine (New York, NY, USA) sought to understand the relationship between urinary exo-miR expression and children's BP and estimated glomerular filtration rate (eGFR) as well as urinary sodium and potassium levels as correlates of heart and kidney health.
For this study, the investigators extracted exo-miRs from urine samples obtained from 88 healthy Mexican children aged four to six years. The study was conducted in Mexico, since children there are considered to be at much higher risk than American children for many heart and kidney problems. Differential centrifugation of spot urines enabled isolation and detection of 193 exo-miRs. Linear regression was then used to analyze the relationship between the extracted exo-miRs and children's BP, eGFR, and urine electrolyte levels.
Results revealed that three exo-miRs had increased expression with urinary sodium, 17 with urinary sodium-to-potassium ratio, and one with decreased estimated glomerular filtration rate.
"Our findings are encouraging for future studies of noninvasive indicators of kidney and heart health, especially for individuals at an increased risk of kidney dysfunction," said senior author Dr. Alison Sanders, assistant professor of environmental medicine, public health, and pediatrics at Mount Sinai School of Medicine. "Further research may discover different combinations of miRNAs that could inform early diagnosis of a wide range of kidney and cardiac diseases. So many children around the world are at risk of developing cardiorenal problems which can impact their health throughout their lives. Assessment of microRNA expression on a targeted scale could present valuable opportunities to detect and intervene with kidney disease before it can progress. That is why we are so encouraged by our team's work in this vital field."
The urinary microRNA study was published in the February 26, 2021, online edition of the journal Epigenomics.
Related Links:
Mount Sinai School of Medicine
Latest Molecular Diagnostics News
- ctDNA Blood Test Could Help Guide Radiotherapy in Patients with Limited Metastases
- FDA-Approved MRD Blood Test Guides Adjuvant Bladder Cancer Therapy
- Tumor Genomic Profiling Identifies High-Risk Gallbladder Cancer
- Novel Algorithm Improves Detection of B-ALL Gene Fusions
- Rapid Multiplex PCR Test Detects 11 Gastrointestinal Pathogens from Single Sample
- Sensitive Protein Marker Aids Diagnosis of Small Cell Prostate Cancer
- Genome Sequencing Uncovers Hidden Genetic Risks in Healthy Adults
- Gene Panel Shows Promise for Predicting Chemotherapy Response in TNBC
- Realistic Mock Samples Aim to Speed Cervical Cancer Test Development
- Blood-Based “Ageing Clock” Helps Predict Dementia Risk and Earlier Onset
- Molecular Marker Identifies Hormone Therapy Resistance Pathway in Prostate Cancer
- Blood Test Refines Biopsy Decisions in Prostate Cancer
- Digital Aging Twin Quantifies Biological Aging Across Multiple Organ Systems
- Emerging Biomarkers Advance Early Detection of MASLD and Liver Cancer Risk
- Urine Test Beats MRI in Identifying Prostate Cancer Upgrading During Active Surveillance
- Finger-Prick Blood Test Aids Early Tuberculosis Detection and Risk Stratification
Channels
Clinical Chemistry
view channel
Urine-Based Nanosensor Tracks Lung Cancer and Fibrosis Noninvasively
Lung cancer remains difficult to monitor for early progression and treatment resistance, while pulmonary fibrosis continues to pose major challenges for early diagnosis. Clinicians need repeatable, noninvasive... Read more
Blood-Based Alzheimer’s Test Gains CE Mark for Amyloid Pathology Detection
Alzheimer’s disease is the most common cause of dementia, yet confirmatory testing remains invasive and hard to access. Diagnosis currently takes an average of 3.5 years, and about 75% of people with dementia... Read moreHematology
view channel
Stem Cell Biomarkers May Guide Precision Treatment in Acute Myeloid Leukemia
Acute myeloid leukemia (AML) is an aggressive blood cancer that most often affects older adults and still carries a poor prognosis despite therapeutic advances. Venetoclax-based regimens have improved... Read more
Advanced CBC-Derived Indices Integrated into Hematology Platforms
Diatron, a STRATEC brand, has introduced six advanced hematological indices on its Aquila, Aquarius 3, and Abacus 5 hematology analyzers. The new Research Use Only (RUO) indices include Neutrophil-to-Lymphocyte... Read moreImmunology
view channel
Routine TB Screening Test May Reveal Immune Aging and Mortality Risk
Immune aging is associated with weaker responses to vaccination, greater risks of infection, and higher levels of inflammation. Leveraging routinely ordered laboratory tests to quantify that responsiveness... Read more
Biomarkers and Molecular Testing Advance Precision Allergy Care
Allergic diseases often present with similar symptoms but can be driven by distinct biological mechanisms, making standardized care inefficient for many patients. Historically, individuals with pollen... Read moreMicrobiology
view channel
Study Finds Hidden Mpox Infections May Drive Ongoing Spread
Mpox continues to circulate despite vaccination, and many cases show no known link to a symptomatic partner. The role of people without symptoms has remained uncertain, limiting clarity on how transmission persists.... Read more
Large-Scale Genomic Surveillance Tracks Resistant Bacteria Across European Hospitals
Antimicrobial resistance (AMR) poses a growing threat to patient safety, with carbapenem-resistant Enterobacterales causing difficult-to-treat infections and leaving clinicians with limited therapeutic options.... Read more
Molecular Urine and Stool Tests Do Not Improve Early TB Treatment in Hospitalized HIV Patients
Tuberculosis is the leading cause of death among people living with HIV, and diagnosis in hospital settings remains difficult. Symptoms are often non-specific, disease can be extrapulmonary, and many patients... Read morePathology
view channel
Rapid AI Tool Predicts Cancer Spatial Gene Expression from Pathology Images
Gene expression profiling can inform tumor biology and treatment selection, but spatial assays remain costly and time-consuming. Results can take weeks and cost thousands of dollars, limiting large-scale... Read more
AI Pathology Test Receives FDA Breakthrough for Bladder Cancer Risk Stratification
Non–muscle invasive bladder cancer has highly variable outcomes, complicating surveillance and treatment planning. Risk assessment typically relies on stage, grade, and tumor size, leaving uncertainty... Read moreTechnology
view channel
Point-of-Care Testing Enhances Health Literacy and Self-Management in Chronic Disease
Limited access to general practitioners and pathology services can delay diagnosis and monitoring for people in regional and remote communities. Rapid, on-the-spot testing can shorten turnaround times... Read more
Fully Automated Sample-to-Insight Workflow Advances Latent TB Testing
Latent tuberculosis remains a substantial testing workload for clinical laboratories as screening programs expand. Despite this growth, only about 40% of testing has shifted from traditional skin tests... Read moreIndustry
view channel
AI-Powered Multi-Functional Analyzer Wins German Innovation Award
Hematology services are increasingly delivered across distributed care settings, where limited staffing and complex workflows can extend turnaround times. Advanced morphology review still often depends... Read more








